Licensed pharmaceutical wholesaler and exporter in India New Delhi · Mumbai[email protected]
Oncology

Erlotinib

Erlotinib is a prescription medicine. Pharmacotherapeutic group: antineoplastic agent, protein kinase inhibitor (ATC code L01EB02). Bio Bridge Pharma supplies it from India to hospitals, licensed importers, distributors and tender buyers outside India.

  • Prescription medicine
  • Named patient supply where allowed

Presentations we supply

  • Tablet 100 mg
  • Tablet 150 mg

Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.

Send Enquiry for Erlotinib

Reference information

Summarised from the product information for Tarceva. Always follow the product information approved in your own country.

Active substance
Erlotinib
Pharmacotherapeutic group
Antineoplastic agent, protein kinase inhibitor (ATC code L01EB02)
Authorised uses
  • First-line locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations
  • Switch maintenance in EGFR-mutation NSCLC with stable disease after first-line chemotherapy
  • NSCLC after at least one prior chemotherapy regimen has failed
  • Metastatic pancreatic cancer, with gemcitabine
Storage (unopened)
No special storage conditions.
Shelf life (unopened)
4 years
Container and pack
PVC blisters sealed with aluminium foil; packs of 30 tablets

Supply from Bio Bridge Pharma

  • The registration route and import licence are confirmed for your destination before we make an offer.
  • Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
  • Named patient supply where the destination country's rules allow it.

Sources

  1. Product information for Tarceva: www.ema.europa.eu
Enquiries

Need a medicine supplied outside India?

Send the product, strength and destination country. We confirm the registration route and import licence for that destination, then send our offer.

Send Enquiry